United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape

The United States generic drugs market is expected to grow at a CAGR of around 10.3% during 2021-2027. This report on United States generic drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States generic drugs market by segmenting the market based on type, therapy area, drug delivery, and distribution channel. Also, detailed profiles of companies operating in the United States generic drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Increasing Prevalence of Chronic Diseases
• Growth in Geriatric Population
• Increasing Investments in Advertising

Market Challenges

• Stringent Governmental Regulations
• Adverse Effects Associated With Drugs

Historical & Forecast Period

Base Year: 2020
Historical Period: 2016-2019
Forecast Period: 2021-2027

Market by Type

• Unbranded
• Branded

Market by Therapy Area

• CNS
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Market by Drug Delivery

• Oral
• Injectable
• Dermal/Topical
• Inhalers

Market by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. United States Generic Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. United States Generic Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. United States Generic Drugs Market by Type
5.1. Introduction
5.2 Unbranded
5.3 Branded
6. United States Generic Drugs Market by Therapy Area
6.1 Introduction
6.2 CNS
6.3 Cardiovascular
6.4 Dermatology
6.5 Genitourinary/Hormonal
6.6 Respiratory
6.7 Rheumatology
6.8 Diabetes
6.9 Oncology
6.10 Others
7. United States Generic Drugs Market by Drug Delivery
7.1 Introduction
7.2 Oral
7.3 Injectable
7.4 Dermal/Topical
7.5 Inhalers
8. United States Generic Drugs Market by Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacies
8.3 Retail Pharmacies
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1 Competitive Scenario
12.2 Company Profiles
12.2.1 Teva
12.2.2 Mylan
12.2.3 Actavis (Teva)
12.2.4 Sandoz (Novartis)
12.2.5 Sun Pharma
12.2.6 Par Pharmaceuticals (Endo Pharmaceuticals)
12.2.7 Lupin Pharmaceuticals
12.2.8 Dr Reddy’s
12.2.9 Hospira (Pfizer)
12.2.10 Baxter International Inc
12.2.11 GlaxoSmithKline Plc.
12.2.12 Eli Lilly and Company
12.2.13 ALLERGAN
12.2.14 STADA Arzneimittel AG
12.2.15 Abbott Laboratories

List of Figures

Figure 1: United States Generic Drugs Market (in US$ Million), 2016-2020
Figure 2: United States Generic Drugs Market by Type, 2020
Figure 3: United States Generic Drugs Market by Therapy Area, 2020
Figure 4: United States Generic Drugs Market by Drug Delivery, 2020
Figure 5: United States Generic Drugs Market by Distribution Channel, 2020
Figure 6: United States Generic Drugs Market (in US$ Million), 2021-2027
Figure 7: United States Generic Drugs Market by Type (in %), 2020 & 2027
Figure 8: United States Unbranded Generic Drugs Market (in US$ Million), 2016-2020
Figure 9: United States Unbranded Generic Drugs Market (in US$ Million), 2021-2027
Figure 10: United States Branded Generic Drugs Market (in US$ Million), 2016-2020
Figure 11: United States Branded Generic Drugs Market (in US$ Million), 2021-2027
Figure 12: United States Generic Drugs Market by Therapy Area (in %), 2020 & 2027
Figure 13: United States CNS Generic Drugs Market (in US$ Million), 2016-2020
Figure 14: United States CNS Generic Drugs Market (in US$ Million), 2021-2027
Figure 15: United States Cardiovascular Generic Drugs Market (in US$ Million), 2016-2020
Figure 16: United States Cardiovascular Generic Drugs Market (in US$ Million), 2021-2027
Figure 17: United States Dermatology Generic Drugs Market (in US$ Million), 2016-2020
Figure 18: United States Dermatology Generic Drugs Market (in US$ Million), 2021-2027
Figure 19: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2016-2020
Figure 20: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2021-2027
Figure 21: United States Respiratory Generic Drugs Market (in US$ Million), 2016-2020
Figure 22: United States Respiratory Generic Drugs Market (in US$ Million), 2021-2027
Figure 23: United States Rheumatology Generic Drugs Market (in US$ Million), 2016-2020
Figure 24: United States Rheumatology Generic Drugs Market (in US$ Million), 2021-2027
Figure 25: United States Diabetes Generic Drugs Market (in US$ Million), 2016-2020
Figure 26: United States Diabetes Generic Drugs Market (in US$ Million), 2021-2027
Figure 27: United States Oncology Generic Drugs Market (in US$ Million), 2016-2020
Figure 28: United States Oncology Generic Drugs Market (in US$ Million), 2021-2027
Figure 29: United States Others Generic Drugs Market (in US$ Million), 2016-2020
Figure 30: United States Others Generic Drugs Market (in US$ Million), 2021-2027
Figure 31: United States Generic Drugs Market by Drug Delivery (in %), 2020 & 2027
Figure 32: United States Oral Generic Drugs Market (in US$ Million), 2016-2020
Figure 33: United States Oral Generic Drugs Market (in US$ Million), 2021-2027
Figure 34: United States Injectable Generic Drugs Market (in US$ Million), 2016-2020
Figure 35: United States Injectable Generic Drugs Market (in US$ Million), 2021-2027
Figure 36: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2016-2020
Figure 37: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2021-2027
Figure 38: United States Inhalers Generic Drugs Market (in US$ Million), 2016-2020
Figure 39: United States Inhalers Generic Drugs Market (in US$ Million), 2021-2027
Figure 40: United States Generic Drugs Market by Distribution Channel (in %), 2020 & 2027
Figure 41: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2016-2020
Figure 42: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2021-2027
Figure 43: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2016-2020
Figure 44: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2021-2027
Figure 45: Market Value Chain

List of Tables

Table 1: United States Generic Drugs Market Portraiture
Table 2: United States Generic Drugs Market by Type (in US$ Million), 2020 & 2027
Table 3: United States Generic Drugs Market by Therapy Area (in US $ Million), 2020 & 2027
Table 4: United States Generic Drugs Market by Drug Delivery (in US $ Million), 2020 & 2027
Table 5: United States Generic Drugs Market by Distribution Channel (in US$ Million), 2020 & 2027
Table 6: List of Key Players